Status:
COMPLETED
HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program
Lead Sponsor:
University of North Carolina, Chapel Hill
Conditions:
Myocardial Infarction
Acute Coronary Syndrome
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The purpose of this implementation trial is to execute a nurse-led, home-based cardiac rehabilitation (HBCR) program, evaluate the program's impact on patient outcomes over 6 months; and compare outco...
Detailed Description
Despite being recognized as a class 1 recommendation by the American Heart Association (AHA), traditional CR is underused: only 20% of patients who need CR are referred, and only half of those referre...
Eligibility Criteria
Inclusion
- Individuals are eligible for the HeartHome study if they meet all the following inclusion criteria:
- Diagnosed with one of the following conditions: myocardial infarction (MI)/acute coronary syndrome (ACS), ST-elevation myocardial infarction (STEMI), non-STEMI, percutaneous coronary intervention (PCI) or stable angina;
- Decline traditional cardiac rehab or do not respond to traditional cardiac rehab enrollment methods;
- Willing to have a nurse visit them in their home and receive follow-up phone calls and text messages for a 12-week intervention period;
- Understand the requirements of participation in and consent to the HeartHome program;
- Live within a 75-mile radius of the study site.
- Individuals are not eligible for the HeartHome study if they meet any of the following exclusion criteria:
- Diagnosis of heart failure
- Diagnosis of valvular heart disease
- Presence of cardiac disease requiring surgery or other invasive procedure
- Impaired mental capacity resulting in an inability to understand or follow directions and study protocol
- Impaired functional abilities that prevent them from participating in physical activity
- Presence of any serious medical conditions that are likely to cause premature death or to impair functional capacity
- No access to a telephone
Exclusion
Key Trial Info
Start Date :
November 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 11 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04131816
Start Date
November 10 2019
End Date
February 11 2022
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNC Health Care
Chapel Hill, North Carolina, United States, 27514